ANGN
insider transactionsAngion Biomedica Corp. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Chief Scientific Officer
$0
41.6K sh
Own New
-
Grant·A
Chief Scientific Officer
$0
20.8K sh
Own +2799%
-
Grant·A
See Remarks
$0
50.9K sh
Own New
-
Grant·A
See Remarks
$0
25.4K sh
Own +79%
-
Grant·A
Connelly Robert KEY
CEO, President and Director
$0
147.2K sh
Own New
-
Grant·A
Connelly Robert KEY
CEO, President and Director
$0
73.6K sh
Own +157%
-
Grant·A
See Remarks
$0
47.9K sh
Own New
-
Grant·A
See Remarks
$0
24.0K sh
Own New
-
Exercise·M
Chief Scientific Officer
$0
362 sh
Own New
-
Exercise·M
Chief Scientific Officer
$1.6K
362 sh · $4.41
Own +95%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Feb 2, 2026 | DeMuth Peter | Grant A | 41.6K | $0 |
| Feb 2, 2026 | DeMuth Peter | Grant A | 20.8K | $0 |
| Feb 2, 2026 | Haqq Christopher | Grant A | 50.9K | $0 |
| Feb 2, 2026 | Haqq Christopher | Grant A | 25.4K | $0 |
| Feb 2, 2026 | Connelly Robert KEY | Grant A | 147.2K | $0 |
| Feb 2, 2026 | Connelly Robert KEY | Grant A | 73.6K | $0 |
| Feb 2, 2026 | Shah Preetam | Grant A | 47.9K | $0 |
| Feb 2, 2026 | Shah Preetam | Grant A | 24.0K | $0 |
| Dec 9, 2025 | DeMuth Peter | Exercise M | 362 | $0 |
| Dec 9, 2025 | DeMuth Peter | Exercise M | 362 | $1.6K |
About ANGN insider trading
This page tracks insider transactions for Angion Biomedica Corp. (ANGN) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.